Oncodermatology News: Topical BRAF Inhibitor Gel May Relieve Anti-EGFR Therapy-related Skin Rash
A novel topical BRAF inhibitor gel called LUT014 may significantly reduce the severity of acneiform rashes, common and painful side effects experienced by patients undergoing anti-epidermal growth factor (EGFR) therapies for colorectal cancer.